Menu

Blog

Archive for the ‘neuroscience’ category: Page 568

Jul 1, 2021

Brain Circuit for Spirituality Identified

Posted by in categories: biotech/medical, neuroscience

Of the 88 neurosurgical patients, 30 showed a decrease in self-reported spiritual belief before and after neurosurgical brain tumor resection, 29 showed an increase, and 29 showed no change. Using lesion network mapping, the team found that self-reported spirituality mapped to a specific brain circuit centered on the PAG. The circuit included positive nodes and negative nodes — lesions that disrupted these respective nodes either decreased or increased self-reported spiritual beliefs.


Summary: A new study has identified a specific brain circuit centered in the periaqueductal gray that is linked to spiritual acceptance and religiosity.

Source: Brigham and Women’s Hospital

Continue reading “Brain Circuit for Spirituality Identified” »

Jun 30, 2021

Newly Discovered ‘Sleeper Phase’ in Stem Cells Could Advance Brain Tumor Treatment

Posted by in categories: biotech/medical, neuroscience

The human body contains hundreds of different types of cells, with stem cells working like blank canvases that can be adapted and reproduced to help our tissues grow and repair themselves. However, once hijacked, the same kind of cell proliferation can be damaging, as happens in cancer tumors.

Scientists have now discovered a new resting phase for neuroepithelial cells — the stem cells of the central nervous system — which appears to put them in a kind of dormancy. If we can work out how to apply this to cancer cells too, we could get to the stage of being able to put brain tumors to ‘sleep’.

“The primary feature of any cancer is that the cells are proliferating,” says biomedical engineer Christopher Plaisier, from Arizona State University. “If we could get in there and figure out what the mechanisms are, that might be a place to slow them down.”

Jun 29, 2021

Neuroscientists uncover neuronal circuitry controlling auditory sensory perception

Posted by in category: neuroscience

A team of neuroscientists at the Beckman Institute for Advanced Science and Technology, led by Baher Ibrahim and Dr. Daniel Llano, has published a study in eLife that furthers our understanding of how the brain perceives everyday sensory inputs.

“There is a traditional idea that the way that we experience the world is sort of like a movie being played on a projector. All the sensory information that is coming in is being played on our and that’s how we see things and hear things,” said Llano, a Beckman researcher and associate professor in the Department of Molecular and Integrative Physiology at the University of Illinois Urbana-Champaign.

However, quite a few studies over the years have challenged this traditional view of how we perceive the world. These studies present a new model: Rather than projecting information onto the , the thalamus might be selecting information that is already present in the cortex, based on our learned experiences.

Jun 29, 2021

Beer yeast genetically engineered to detect and treat gut inflammation

Posted by in categories: biotech/medical, genetics, neuroscience

Researchers from Brigham and Women’s Hospital have engineered yeast used in baking, wine-making and brewing to treat inflammatory bowel disease (IBD). The bacteria has been modified to secrete an anti-inflammatory molecule in response to signs of gut inflammation and has proven effective in preclinical tests.

Our gut microbiome is increasingly implicated in everything from cancer to neurodegenerative disease but it is still unclear exactly how we can translate these novel findings into clinical treatments. Fecal transplants are probably the most primitive microbiome-modifying treatment we have developed, while probiotics simply rely on upping specific levels of naturally occurring bacteria.

Perhaps the most futurist microbiome therapy under investigation is the idea of genetically engineered probiotics. Here researchers modify bacteria to either eat up molecules we don’t want in our body or secrete molecules we know have positive therapeutic effects.

Jun 29, 2021

Prevailing Alzheimer’s Theory in Question With New Discovery

Posted by in categories: biotech/medical, neuroscience

Summary: Study finds amyloid-beta plaques may not be the cause of memory loss associated with Alzheimer’s disease, but instead a consequence of the disease. Regardless of the levels of amyloid plaques, researchers found individuals with high levels of amyloid peptide were cognitively normal. Higher levels of soluble amyloid beta peptide were also linked to people having a larger hippocampus.

Source: University of Cincinnati.

Experts estimate more than 6 million Americans are living with Alzheimer’s dementia. But a recent study, led by the University of Cincinnati, sheds new light on the disease and a highly debated new drug therapy.

Jun 28, 2021

A Never-Before-Seen Type of Signal Has Been Detected in The Human Brain

Posted by in categories: biotech/medical, food, genetics, neuroscience

Scientists develop the first CRISPR-Cas9-based gene drive in plants which may breed crops better able to withstand drought and disease.


Scientists have discovered a unique form of cell messaging occurring in the human brain that’s not been seen before. Excitingly, the discovery hints that our brains might be even more powerful units of computation than we realized.

Early last year, researchers from institutes in Germany and Greece reported a mechanism in the brain’s outer cortical cells that produces a novel ‘graded’ signal all on its own, one that could provide individual neurons with another way to carry out their logical functions.

Continue reading “A Never-Before-Seen Type of Signal Has Been Detected in The Human Brain” »

Jun 28, 2021

Mind-Blowing ‘Inflatable’ Spinal Cord Implant Could Make Pain Relief Widely Available

Posted by in categories: biotech/medical, neuroscience

Scientists have revealed a fascinating new design for an incredibly tiny, inflatable spinal cord implant, suited for treating severe chronic back pain that doesn’t respond to medication.

The inflatable electronic device is part of a spinal cord stimulator (SCS) setup, a type of well-established therapy that delivers mild electric currents to a person’s spinal cord via implanted electrodes. That current is sent by a small, implanted pulse generator device, and the whole thing reduces pain because the electrical pulses help to mask pain signals traveling to the brain via the spinal cord.

If that all sounds rather invasive, that’s because it is. But this new device, designed by a team led by scientists from the University of Cambridge in the UK, could help to change that — with less invasive surgery requirements.

Jun 28, 2021

Statins Used to Lower Cholesterol Linked to Doubled Risk of Developing Dementia

Posted by in categories: biotech/medical, health, neuroscience

If concerned, speak to your physician.


In patients with mild cognitive impairment, taking lipophilic statins more than doubles their risk of developing dementia compared to those who do not take statins. According to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting, positron emission tomography (PET) scans of lipophilic statin users revealed a highly significant decline in metabolism in the area of the brain that is first impacted by Alzheimer’s disease.

Statins are medications used to lower cholesterol and reduce the risk of heart attack or stroke. They are the most commonly used drugs in the developed world, and nearly 50 percent of Americans over age 75 use a statin. Different types of statins are available based on a patient’s health needs, including hydrophilic statins that focus on the liver and lipophilic statins that are distributed to tissues throughout the body.

Continue reading “Statins Used to Lower Cholesterol Linked to Doubled Risk of Developing Dementia” »

Jun 27, 2021

IQ Tests Can’t Measure It, but ‘Cognitive Flexibility’ Is Key to Learning and Creativity

Posted by in categories: innovation, neuroscience

Flexible thinking is key to creativity – in other words, the ability to think of new ideas, make novel connections between ideas, and make new inventions. It also supports academic and work skills such as problem solving. That said, unlike working memory – how much you can remember at a certain time – it is largely independent of IQ, or “crystallised intelligence”.


IQ is often hailed as a crucial driver of success, particularly in fields such as science, innovation and technology. In fact, many people have an endless fascination with the IQ scores of famous people. But the truth is that some of the greatest achievements by our species have primarily relied on qualities such as creativity, imagination, curiosity and empathy.

Continue reading “IQ Tests Can’t Measure It, but ‘Cognitive Flexibility’ Is Key to Learning and Creativity” »

Jun 26, 2021

CRISPR gene editing breakthrough could treat many more diseases

Posted by in categories: bioengineering, biotech/medical, genetics, nanotechnology, neuroscience

CRISPR gene editing already promises to fight diseases that were once thought unassailable, but techniques so far have required injecting the tools directly into affected cells. That’s not very practical for some conditions. However, there’s just been a breakthrough. NPR reports that researchers have published results showing that you can inject CRISPR-Cas9 into the bloodstream to make edits, opening the door to the use of gene editing for treating many common diseases.

The experimental treatment tackled a rare genetic disease, transthyretin amyloidosis. Scientists injected volunteers with CRISPR-loaded nanoparticles that were absorbed by the patients’ livers, editing a gene in the organ to disable production of a harmful protein. Levels of that protein plunged within weeks of the injection, saving patients from an illness that can rapidly destroy nerves and other tissues in their bodies.

The test involved just six people, and the research team still has to conduct long-term studies to check for possible negative effects. If this method proves viable on a large scale, though, it could be used to treat illnesses where existing CRISPR techniques aren’t practical, ranging from Alzheimer’s to heart disease.

Page 568 of 1,030First565566567568569570571572Last